IRIS
BRAVACCINI, SARA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 374
NA - Nord America 320
AS - Asia 182
OC - Oceania 2
Totale 878
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 311
IE - Irlanda 224
SG - Singapore 172
DE - Germania 47
IT - Italia 24
NL - Olanda 20
FI - Finlandia 19
CA - Canada 9
FR - Francia 7
BE - Belgio 6
CZ - Repubblica Ceca 6
LT - Lituania 6
AT - Austria 5
CN - Cina 5
GB - Regno Unito 5
HK - Hong Kong 4
RU - Federazione Russa 3
AU - Australia 2
IN - India 1
PL - Polonia 1
UA - Ucraina 1
Totale 878
Salva come PNG Salva come JPEG
Città #
Dublin 224
Santa Clara 130
Boardman 129
Singapore 121
Munich 24
Amsterdam 19
Helsinki 19
Ashburn 11
Frankfurt am Main 8
Milan 7
Brno 6
Brussels 6
Lugo 5
Toronto 5
Vienna 5
Chicago 4
Hong Kong 4
Ottawa 4
Paris 4
London 3
Nuremberg 2
Ponsacco 2
Bhubaneswar 1
Crescentino 1
Fuzhou 1
Gatchina 1
Purmerend 1
Rimini 1
Shanghai 1
St Petersburg 1
Stockton-on-Tees 1
Villa Cortese 1
Warsaw 1
Totale 753
Salva come PNG Salva come JPEG
Nome #
Chronological age or biological age: What drives the choice of adjuvant treatment in elderly breast cancer patients? 27
The use of platelets as a clinical tool in oncology: opportunities and challenges 18
Biomarkers: which ones do we really need today? 17
A Novel AKT1, ERBB2, ESR1, KRAS, PIK3CA, and TP53 NGS Assay: A Non-Invasive Tool to Monitor Resistance Mechanisms to Hormonal Therapy and CDK4/6 Inhibitors 16
Re: Clinicopathological features and outcomes comparing patients with invasive ductal and lobular breast cancer 15
Urinary Biomarkers in Tumors: An Overview 15
Appropriateness and Economic Analysis of Conventional Circulating Biomarkers Assessment in Early Breast Cancer: A Real-World Experience from the E.Pic.A Study 14
Atezolizumab Plus Nab-paclitaxel in PD-L1-Positive TNBC-Letter 14
In-111-Pentetreotide (OctreoScan) scintigraphy in the staging of small-cell lung cancer: its accuracy and prognostic significance 14
Are Androgen and Estrogen Receptors in DCIS Patients Prognostic Indicators of Relapse Independently of Treatment? 14
Ki67 and PR in patients treated with CDK4/6 Inhibitors: A real-world experience 13
Cell-free DNA detected by "liquid biopsy" as a potential prognostic biomarker in patients with different subtypes of breast cancer 13
A functional survey of the regulatory landscape of estrogen-receptor-positive breast cancer evolution 13
Safety and efficacy of anti-PD-1 inhibitors in Chinese patients with advanced lung cancer and hepatitis B virus infection: a retrospective single-center study 13
Setting Up a Medical Oncology Educational Program in Sub-Saharan Africa 12
Cell-free DNA detected by "liquid biopsy" as a potential prognostic biomarker in early breast cancer 12
T-Cell Receptor Repertoire Sequencing and Its Applications: Focus on Infectious Diseases and Cancer 12
An initiative to assess the quality of Tanzanian cervical cancer specimens for HPV and telomerase detection 12
Frequency of Actionable Alterations in EGFR wt NSCLC: Experience of the Wide Catchment Area of Romagna (AVR) 12
Molecular characterization of cytotoxic and drug resistance mechanisms induced by NCX 4040, a novel NO-NSAID, in pancreatic cancer cell lines 12
Androgen receptor signaling pathways as a target for breast cancer treatment 12
Are BMI and Negative Hormone Receptors Prognostic Factors in HER2+ Early-stage Breast Cancer? 12
Androgen receptor in breast cancer: The "5W" questions 12
Fluorescence In Situ Hybridization in Urine Samples (UroVysion Kit) 12
Tumor resident microbiota and response to therapies: An insight on tissue bacterial microbiota 11
Evaluating the appropriateness of chemotherapy in a low-resource cancer centre in sub-Saharan Africa 11
Combining preclinical tools and models to unravel tumor complexity: Jump into the next dimension 11
Combined Oral Fentanyl Citrate and Midazolam as Premedication for Bone Marrow Aspiration and Biopsy in Patients with Hematological Malignancies: A Randomized, Controlled and Patient-Blinded Clinical Trial 11
NMR-Based Metabolomic Approach Tracks Potential Serum Biomarkers of Disease Progression in Patients with Type 2 Diabetes Mellitus 11
Proposed clinical phases for the improvement of personalized treatment of checkpoint inhibitor-related pneumonitis 11
What to look for in cell-free DNA from breast cancer patients 11
Impressive clinical response to anti-PD-1 therapy in epithelioid mesothelioma with high clonal PD-L1 expression and EML4-ALK rearrangement 11
Are There Differences in Androgen Receptor Expression in Invasive Breast Cancer in African (Tanzanian) Population in Comparison With the Caucasian (Italian) Population? 11
Telomerase Activity Analysis In Urine Sediment for Bladder Cancer 11
An H-1 NMR study of the cytarabine degradation in clinical conditions to avoid drug waste, decrease therapy costs and improve patient compliance in acute leukemia 11
Sacituzumab govitecan: a new opportunity in the treatment of refractory metastatic triple-negative breast cancer 11
TMB in NSCLC: A Broken Dream? 10
Pro-apoptotic effect of a nitric oxide-donating NSAID, NCX 4040, on bladder carcinoma cells 10
Frequency of actionable alterations in epidermal growth factor receptor (EGFR) wild type non-small cell lung cancer: experience of the Wide Catchment Area of Romagna (AVR) 10
Palbociclib (PD 0332991): targeting the cell cycle machinery in breast cancer 10
Is Ki67 still a powerful ally in predicting the clinical benefit of anthracyclines for the adjuvant treatment of early breast cancer? 10
What Influences the Choice of Ibrutinib-Rituximab vs Classic Chemoimmunotherapy for Chronic Lymphocytic Leukemia? 10
Spotlight on PSMA as a new theranostic biomarker for bladder cancer 10
Trop-2 Therapy in Metastatic Triple-Negative Breast Cancer in Italy: Clinical Opportunity and Regulatory Pitfalls 10
Usefulness of immunological detection of the human telomerase reverse transcriptase 10
Urine cell-free DNA integrity as a marker for early bladder cancer diagnosis: preliminary data 10
International consensus on severe lung cancer-the first edition 10
No more disparities among regions in Italy: recent approval of genomic test reimbursability for early breast cancer patients in the country 10
Combined analysis of miR-200 family and its significance for breast cancer 9
Are we ready to use TMB in breast cancer clinical practice? 9
An Italian Real-World Study Highlights the Importance of Some Clinicopathological Characteristics Useful in Identifying Metastatic Breast Cancer Patients Resistant to CDK4/6 Inhibitors and Hormone Therapy 9
Programmed death ligand 1 expression in early stage, resectable non-small cell lung cancer 9
Sorafenib for the treatment of breast cancer 9
Urine telomerase: An important marker in the diagnosis of bladder cancer 8
The Expression of Programmed Death Ligand 1 and Vimentin in Resected Non-Metastatic Non-Small-Cell Lung Cancer: Interplay and Prognostic Effects 8
Predictive role of multiple gene alterations in response to cetuximab in metastatic colorectal cancer: A single center study 8
Expanding Roles of De Novo Lipogenesis in Breast Cancer 8
Triple negative breast cancer in a poor resource setting in North-Western Tanzania: a preliminary study of 52 patients 8
Biofunctional characteristics of in situ and invasive breast carcinoma 8
Emerging Roles of Aldehyde Dehydrogenase Isoforms in Anti-cancer Therapy Resistance 8
ALK translocation detection in non-small cell lung cancer cytological samples obtained by TBNA or EBUS-TBNA 8
Androgen and oestrogen receptors as potential prognostic markers for patients with ductal carcinoma insitu treated with surgery and radiotherapy 8
Carbonic Anhydrase XII Expression Is Modulated during Epithelial Mesenchymal Transition and Regulated through Protein Kinase C Signaling 8
CAR T cells targeting options in the fight against multiple myeloma 8
International expert consensus on diagnosis and treatment of lung cancer complicated by chronic obstructive pulmonary disease. 8
Single-cell transcriptomics reveals multi-step adaptations to endocrine therapy 8
Benefit from anthracyclines in relation to biological profiles in early breast cancer 8
Analysis of Genetic Alterations in Tunisian Patients with Lung Adenocarcinoma 8
Paraneoplastic lipase and amylase production in a patient with small-cell lung cancer: case report 7
Androgen receptor in breast cancer: A wolf in sheep's clothing? A lesson from prostate cancer 7
Impressive long-term response with chemo-endocrine therapy in a premenopausal patient with metastatic breast cancer A case report 7
Role of Telomerase in Cervical Lesions as Prognostic Marker: A Comparison Between Immunohistochemistry and Fluorescence In Situ Hybridization 7
Combining cytology, TRAP assay, and FISH analysis for the detection of bladder cancer in symptomatic patients 7
Accuracy of urine telomerase activity to detect bladder cancer in symptomatic patients 7
Epithelial-to-mesenchymal transition in the context of epidermal growth factor receptor inhibition in non-small-cell lung cancer 7
Why the complications of COVID-19 patients differ in elderly and young cancer patients 7
Erratum to: Benefit from anthracyclines in relation to biological profiles in early breast cancer 7
Androgen Receptor Expression in Breast Cancer: What Differences Between Primary Tumor and Metastases? 7
Primary epithelioid angiosarcoma of the thyroid: A case report 6
PSMA expression: A potential ally for the pathologist in prostate cancer diagnosis 6
Easily detectable cytomorphological features to evaluate during ROSE for rapid lung cancer diagnosis: from cytology to histology 6
Differences in biological features of breast cancer between Caucasian (Italian) and African (Tanzanian) populations 6
Molecular determinations of EGFR and EML4-ALK on a single slide of NSCLC tissue 6
High consistency between characteristics of primary intraductal breast cancer and subtype of subsequent ipsilateral invasive cancer 6
Pharmacokinetics, pharmacodynamics and clinical efficacy of pertuzumab in breast cancer therapy 6
CD68, CD163, and matrix metalloproteinase 9 (MMP-9) in breast tumor microenvironment to predict breast cancer survival: are they enough? 6
Relevance of urine telomerase in the diagnosis of bladder cancer 6
Androgen receptor in advanced breast cancer: is it useful to predict the efficacy of anti-estrogen therapy? 6
Setting up a community-based cervical screening service in a low-income country: a pilot study from north-western Tanzania 6
Know your enemy: Genetics, aging, exposomic and inflammation in the war against triple negative breast cancer 6
Spotlight on Ki67 as a prognostic marker in early breast cancer: all that glitters may not be gold 6
Epithelial-to-mesenchymal transition and EGFR status in NSCLC: the role of vimentin expression 6
Re: "Evolution of low HER2 expression between early and advanced-stage breast cancer" 6
Are fine-needle aspiration biopsy-derived cell blocks a useful surrogate for tissue samples in breast cancer? 6
Follicular Lymphoma Microenvironment Traits Associated with Event-Free Survival 6
ACE2 and TMPRSS2 Potential Involvement in Genetic Susceptibility to SARS-COV-2 in Cancer Patients 6
The current role of telomerase in the diagnosis of bladder cancer 5
The Interplay Between Programmed Death Ligand 1 and Vimentin in Advanced Non-Small-Cell Lung Cancer 5
What's the best modality for patient selection for predicting response to PD-1/PD-L1 inhibitors? 5
Role of androgen and estrogen receptors as prognostic and potential predictive markers of ductal carcinoma in situ of the breast 5
Totale 951
Salva come PNG Salva come JPEG
Categoria #
all - tutte 10.469
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.469
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/2024187 0 0 0 0 0 0 0 0 0 0 0 187
2024/2025904 264 71 193 57 234 85 0 0 0 0 0 0
Totale 1.091